Zura Bio Ltd (ZURA)
2.93
+0.03
(+1.03%)
USD |
NASDAQ |
Nov 21, 16:00
2.92
-0.01
(-0.34%)
After-Hours: 20:00
Zura Bio Price to Book Value: 1.246 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 20, 2024 | 1.237 |
November 19, 2024 | 1.344 |
November 18, 2024 | 1.370 |
November 15, 2024 | 1.348 |
November 14, 2024 | 1.536 |
November 13, 2024 | 1.869 |
November 12, 2024 | 1.933 |
November 11, 2024 | 2.014 |
November 08, 2024 | 1.954 |
November 07, 2024 | 1.907 |
November 06, 2024 | 1.834 |
November 05, 2024 | 1.753 |
November 04, 2024 | 1.864 |
November 01, 2024 | 1.869 |
October 31, 2024 | 1.877 |
October 30, 2024 | 1.975 |
October 29, 2024 | 1.911 |
October 28, 2024 | 1.967 |
October 25, 2024 | 2.022 |
October 24, 2024 | 1.962 |
October 23, 2024 | 1.980 |
October 22, 2024 | 2.099 |
October 21, 2024 | 2.061 |
October 18, 2024 | 2.099 |
October 17, 2024 | 2.086 |
Date | Value |
---|---|
October 16, 2024 | 1.933 |
October 15, 2024 | 1.775 |
October 14, 2024 | 1.732 |
October 11, 2024 | 1.732 |
October 10, 2024 | 1.647 |
October 09, 2024 | 1.698 |
October 08, 2024 | 1.796 |
October 07, 2024 | 1.817 |
October 04, 2024 | 1.869 |
October 03, 2024 | 1.770 |
October 02, 2024 | 1.694 |
October 01, 2024 | 1.642 |
September 30, 2024 | 1.732 |
September 27, 2024 | 1.658 |
September 26, 2024 | 1.618 |
September 25, 2024 | 1.593 |
September 24, 2024 | 1.630 |
September 23, 2024 | 1.711 |
September 20, 2024 | 1.809 |
September 19, 2024 | 1.752 |
September 18, 2024 | 1.683 |
September 17, 2024 | 1.581 |
September 16, 2024 | 1.463 |
September 13, 2024 | 1.508 |
September 12, 2024 | 1.467 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.237
Minimum
Nov 20 2024
19.80
Maximum
Jun 20 2023
4.010
Average
3.204
Median
Oct 31 2023
Price to Book Value Benchmarks
CEL-SCI Corp | 4.372 |
AIM ImmunoTech Inc | 4.627 |
IGC Pharma Inc | 3.739 |
NovaBay Pharmaceuticals Inc | 3.291 |
Protalix BioTherapeutics Inc | 3.791 |
Price to Book Value Related Metrics
Price | 2.93 |
Earnings Yield | -10.96% |
Market Cap | 190.66M |